Cutaneous follicle center lymphoma, lymph nodes of multiple sites
ICD-10 C82.68 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, lymph nodes of multiple sites.
Cutaneous follicle center lymphoma (CFCL) is a subtype of non-Hodgkin lymphoma that primarily affects the skin and can involve lymph nodes at multiple sites. It is characterized by the proliferation of B-cells that originate from the follicle center of lymphoid tissue. Patients may present with skin lesions that can vary in appearance, including plaques, nodules, or tumors. The disease can be indolent or aggressive, and its progression may lead to lymphadenopathy, particularly in the lymph nodes of multiple sites. Diagnosis typically involves a combination of clinical evaluation, histopathological examination of skin biopsies, and imaging studies to assess lymph node involvement. Staging is crucial for determining the extent of the disease and guiding treatment decisions. B-symptoms, such as fever, night sweats, and weight loss, may be present in some patients, indicating a more advanced disease state. Treatment options may include localized therapies, systemic chemotherapy, immunotherapy, or targeted therapies, depending on the stage and aggressiveness of the lymphoma.
Detailed clinical notes, pathology reports, imaging studies, and treatment plans.
Diagnosis and management of CFCL, staging evaluations, and treatment response assessments.
Ensure comprehensive documentation of symptoms, treatment responses, and follow-up care.
Skin biopsy reports, clinical photographs, and treatment notes.
Evaluation of skin lesions, biopsy for diagnosis, and management of cutaneous manifestations.
Document the appearance and location of skin lesions thoroughly.
Used for biopsy confirmation of CFCL.
Pathology report detailing the findings.
Ensure the report includes specific details about the lymphoma subtype.
Common symptoms include skin lesions, lymphadenopathy, and B-symptoms such as fever, night sweats, and weight loss.
